Adriana Ramos
Principal Scientist, Lab Head Sanofi
Neuroscientist and manager with more than 10 years experience in neuroinflammation research in pharmaceutical and academic settings. Proven project leader with expertise in early discovery projects across modalities. Accomplished experimental neuroimmunologist with experience designing and executing in vitro and in vivo research for neurodegenerative and psychiatric indications. Experienced communicator with a track record of strong matrix collaboration. Successfully supporting public-private and international research collaborations.
Seminars
Thursday 16th April 2026
Translating GLP-1 Agonism to Uncover Novel Mechanisms for Neuroprotection in Alzheimer’s and Parkinson’s Disease
9:00 am
- Investigating how GLP-1-based therapies influence the brain beyond feeding behavior regulation – and their relevance for neurodegenerative disease
- Reconsidering the role of glial cells in mediating therapeutic effects of GLP-1R agonism
- Tracing conserved brain responses to GLP-1 modulation across systems
Thursday 16th April 2026
Fire-Side Discussion: Repurposing GLP-1s to Treat Alzheimer’s & Parkinson’s to Improve Cognitive Function & Reduce Neuroinflammation to Create a New Therapeutic Avenue
12:00 pm
- Diversifying treatment opportunities by investigating GLP-1s for new indications like neurological disorders and addiction to unlock their full therapeutic potential and expand their use beyond cardiometabolic health
- Providing new hope for patients by researching next-generation applications to create therapeutic options for conditions with limited treatments
- Expanding the clinical horizon with a wider range of applications for GLP-1s to establish these therapies as a foundational class of drugs for modern medicine
